SEHK:2291Medical Equipment
LEPU ScienTech Medical Technology SEHK 2291 Margin Decline Tests Bullish Growth Narratives
LEPU ScienTech Medical Technology (Shanghai) (SEHK:2291) opened FY 2025 with first half revenue of C¥329.7 million and basic EPS of C¥0.52, setting the tone for how its profitability story is evolving. Over the recent periods, the company has seen revenue move from C¥249.1 million in 1H 2024 to C¥222.5 million in 2H 2024 and then to C¥329.7 million in 1H 2025, while basic EPS shifted from C¥0.40 to C¥0.30 and then to C¥0.52, giving investors a clear view of how the top and bottom lines are...